Importantly, the agency centered this resolve not on demonstrated damage from widespread adverse function stories, but rather over the absence of enough safety knowledge—a precautionary solution grounded in pharmaceutical regulatory science. U.S. peptide imports from China approximately doubled in 2025, reaching $328 million in the initial 9 months alone—up from https://johnn638piz6.wikiannouncement.com/user